Skp2-Dependent Ubiquitination and Activation of LKB1 Is Essential for Cancer Cell Survival under Energy Stress

被引:102
|
作者
Lee, Szu-Wei [1 ,2 ]
Li, Chien-Feng [5 ,6 ]
Jin, Guoxiang [2 ]
Cai, Zhen [2 ]
Han, Fei [1 ,2 ]
Chan, Chia-Hsin [2 ]
Yang, Wei-Lei [1 ,2 ]
Li, Bin-Kui [2 ]
Rezaeian, Abdol Hossein [2 ]
Li, Hong-Yu [7 ]
Huang, Hsuan-Ying [8 ,9 ]
Lin, Hui-Kuan [1 ,2 ,3 ,4 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[3] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan
[4] Asia Univ, Dept Biotechnol, Taichung 404, Taiwan
[5] Chi Mei Foundat Med Ctr, Dept Pathol, Tainan 710, Taiwan
[6] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan
[7] Univ Arizona, Dept Pharmacol & Toxicol, Coll Pharm, Tucson, AZ 85721 USA
[8] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung 83301, Taiwan
[9] Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan
关键词
TUMOR-SUPPRESSOR LKB1; PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; LKB1-STRAD-MO25; COMPLEX; SKP2; AMPK; PHOSPHORYLATION; TUMORIGENESIS; LOCALIZATION; INACTIVATION;
D O I
10.1016/j.molcel.2015.01.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
LKB1 is activated by forming a heterotrimeric complex with STRAD and MO25. Recent studies suggest that LKB1 has pro-oncogenic functions, besides acting as a tumor suppressor. How the LKB1 activity is maintained and how LKB1 regulates cancer development are largely unclear. Here we show that K63-linked LKB1 polyubiquitination by Skp2-SCF ubiquitin ligase is critical for LKB1 activation by maintaining LKB1-STRAD-MO25 complex integrity. We further demonstrate that oncogenic Ras acts upstream of Skp2 to promote LKB1 polyubiquitination by activating Skp2-SCF ubiquitin ligase. Moreover, Skp2-mediated LKB1 polyubiquitination is required for energy-stress-induced cell survival. We also detected overexpression of Skp2 and LKB1 in late-stage hepatocellular carcinoma (HCC), and their overexpression predicts poor survival outcomes. Finally, we show that Skp2-mediated LKB1 polyubiquitination is important for HCC tumor growth in vivo. Our study provides new insights into the upstream regulation of LKB1 activation and suggests a potential target, the Ras/Skp2/LKB1 axis, for cancer therapy.
引用
收藏
页码:1022 / 1033
页数:12
相关论文
共 50 条
  • [21] AhR activation promotes Treg cell generation by enhancing Lkb1-mediated fatty acid oxidation via the Skp2/K63-ubiquitination pathway
    Zhang, Qin
    Zhu, Yanrong
    Lv, Changjun
    Fang, Yulai
    Liao, Minhui
    Xia, Yufeng
    Wei, Zhifeng
    Dai, Yue
    IMMUNOLOGY, 2023, 169 (04) : 412 - 430
  • [22] Novel PGK1 determines SKP2-dependent AR stability and reprograms granular cell glucose metabolism facilitating ovulation dysfunction
    Liu, Xia
    Sun, Changfa
    Zou, Kexin
    Li, Cheng
    Chen, Xiaojun
    Gu, Hangchao
    Zhou, Zhiyang
    Yang, Zuwei
    Tu, Yaoyao
    Qin, Ningxin
    Zhao, Yiran
    Wu, Yimei
    Meng, Yicong
    Ding, Guolian
    Liu, Xinmei
    Sheng, Jianzhong
    Yu, Chuanjin
    Huang, Hefeng
    EBIOMEDICINE, 2020, 61
  • [23] Carnosic Acid against Lung Cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling
    O'Neill, Eric J.
    Sze, Newman Siu Kwan
    Macpherson, Rebecca E. K.
    Tsiani, Evangelia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [24] Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs
    Cheng, Xinlai
    Kim, Jee Young
    Ghafoory, Shahrouz
    Duvaci, Tijen
    Rafiee, Roya
    Theobald, Jannick
    Alborzinia, Harried
    Holenya, Pavlo
    Fredebohm, Johannes
    Merz, Karl-Heinz
    Mehrabi, Arianeb
    Hafezi, Mohammadreza
    Saffari, Arash
    Eisenbrand, Gerhard
    Hoheisel, Joerg D.
    Woelfl, Stefan
    MOLECULAR ONCOLOGY, 2016, 10 (06) : 806 - 824
  • [25] Sox2 Cooperates with Lkb1 Loss to Promote Mouse Model of Squamous Cell Lung Cancer
    Mukhopadhyay, Anandaroop
    Mollaoglu, Gurkan
    Witt, Benjamin
    Oliver, Trudy G.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S188 - S188
  • [26] SKP2 Contributes to AKT Activation by Ubiquitination Degradation of PHLPP1, Impedes Autophagy, and Facilitates the Survival of Thyroid Carcinoma
    Shao, Yuan
    Ren, Wanli
    Dai, Hao
    Yang, Fangli
    Li, Xiang
    Zhang, Shaoqiang
    Liu, Junsong
    Yao, Xiaobao
    Zhao, Qian
    Sun, Xin
    Zheng, Zhiwei
    Xu, Chongwen
    MOLECULES AND CELLS, 2023, 46 (06) : 360 - 373
  • [27] LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab
    Bonanno, Laura
    De Paoli, Angela
    Zulato, Elisabetta
    Esposito, Giovanni
    Calabrese, Fiorella
    Favaretto, Adolfo
    Santo, Antonio
    Del Conte, Alessandro
    Chilosi, Marco
    Oniga, Francesco
    Sozzi, Gabriella
    Moro, Massimo
    Ciccarese, Francesco
    Nardo, Giorgia
    Bertorelle, Roberta
    Candiotto, Cinzia
    De Salvo, Gian Luca
    Amadori, Alberto
    Conte, PierFranco
    Indraccolo, Stefano
    CLINICAL CANCER RESEARCH, 2017, 23 (13) : 3316 - 3324
  • [28] LKB1 kinase-dependent and -independent defects disrupt polarity and adhesion signaling to create a uniquely invasive amoeboid cancer cell
    Wilkinson, S.
    Konen, J. M.
    Marcus, A.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [29] LKB1/AMPK/TSC2 signaling pathway alterations in non-small cell lung cancer
    De Aguirre, I
    Zhong, D
    Zhou, W
    Rosell, R
    Vertino, P
    LUNG CANCER, 2005, 49 : S69 - S69
  • [30] Lovastatin Induces Multiple Stress Pathways Including LKB1/AMPK Activation That Regulate Its Cytotoxic Effects in Squamous Cell Carcinoma Cells
    Ma, Laurie
    Niknejad, Nima
    Gorn-Hondermann, Ivan
    Dayekh, Khalil
    Dimitroulakos, Jim
    PLOS ONE, 2012, 7 (09):